Covidien raises 2013 outlook as Q1 exceeds expectations

January 25, 2013 by MassDevice staff

Medical device company Covidien increases its guidance for 2013 on above-market growth in its medical device sales and a rosy outlook on emerging markets.

Covidien logo

Medtech titan Covidien (NYSE:COV) gained some points on Wall Street after raising its 2013 sales outlook on the strength of its 1st quarter results and an optimistic outlook on the company's emerging market potential.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.